Top-News
Gesundheitswesen USA

Atossa Therapeutics News

Aktie
WKN:  A2JJ99 ISIN:  US04962H5063 US-Symbol:  ATOS
1,602 €
+0,062 €
+4,03%
22:42:56 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
126,62 Mio.
Marktkapitalisierung *
195,30 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 24.06.2023

Atossa Therapeutics News

07.06.21 - PR Newswire
Thinking about buying stock in Clean Energy Fuels, BlackBerry, Atossa Therapeutics, American Resources, or Nextdecade?
Thinking about buying stock in Clean Energy Fuels, BlackBerry, Atossa Therapeutics, American Resources, or Nextdecade? PR Newswire
27.05.21 - PR Newswire
New Research Demonstrates Claims that the Wuhan Institute of Virology had no cases of COVID-19 are not credible
New Research Demonstrates Claims that the Wuhan Institute of Virology had no cases of COVID-19 are not credible PR Newswire
21.05.21 - PR Newswire
Physician-Scientist Dr. Steven Quay to Brief the U.S. Congress On His Research Investigating the Origin of the COVID-19 Pandemic
Physician-​Scientist Dr. Steven Quay to Brief the U.S. Congress On His Research Investigating the Origin of the COVID-19 Pandemic PR Newswire
20.05.21 - PR Newswire
Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers?
Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers? PR Newswire
30.04.21 - PR Newswire
Thinking about buying stock in Motus GI, Aurinia Pharmaceuticals, Aptose Biosciences, Vaxart, or Atossa Therapeutics?
Thinking about buying stock in Motus GI, Aurinia Pharmaceuticals, Aptose Biosciences, Vaxart, or Atossa Therapeutics? PR Newswire
22.04.21 - PR Newswire
Thinking about buying stock in Novan, Qualtrics International, BioNano Genomics, XL Fleet, or Atossa Therapeutics?
Thinking about buying stock in Novan, Qualtrics International, BioNano Genomics, XL Fleet, or Atossa Therapeutics? PR Newswire
11.03.21 - PR Newswire
Thinking about buying stock in Entera Bio, Atossa Therapeutics, Xpeng, Micron Technology, or Verizon?
Thinking about buying stock in Entera Bio, Atossa Therapeutics, Xpeng, Micron Technology, or Verizon? PR Newswire
05.02.21 - PR Newswire
Thinking about buying stock in Zomedica, Nokia, Zynerba Pharmaceuticals, Senseonics Holdings, or Atossa Therapeutics?
Thinking about buying stock in Zomedica, Nokia, Zynerba Pharmaceuticals, Senseonics Holdings, or Atossa Therapeutics? PR Newswire
04.02.21 - PR Newswire
Thinking about buying stock in Anavex Life Sciences, Lizhi, vTv Therapeutics, Atossa Therapeutics, or Cyclo Therapeutics?
Thinking about buying stock in Anavex Life Sciences, Lizhi, vTv Therapeutics, Atossa Therapeutics, or Cyclo Therapeutics? PR Newswire
29.01.21 - PR Newswire
New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory
New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory Wuhan Institute of Virology Research in December 2019 Shows Evidence of Adenovirus ...
26.01.21 - PR Newswire
Thinking about buying stock in Phio Pharmaceuticals, Allena Pharmaceuticals, Aemetis, Atossa Therapeutics, or Heat Biologics?
Thinking about buying stock in Phio Pharmaceuticals, Allena Pharmaceuticals, Aemetis, Atossa Therapeutics, or Heat Biologics? PR Newswire
25.01.21 - PR Newswire
Thinking about buying stock in Acer Therapeutics, Zomedica, Novan, Atossa Therapeutics, or Tellurian?
Thinking about buying stock in Acer Therapeutics, Zomedica, Novan, Atossa Therapeutics, or Tellurian? PR Newswire
22.01.21 - PR Newswire
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop?
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop? PR Newswire
08.01.21 - PR Newswire
COVID-19 Origin and Spread Linked to PLA Hospital and Wuhan Metro System Line 2 by Physician-Scientist Dr. Steven Quay
COVID-19 Origin and Spread Linked to PLA Hospital and Wuhan Metro System Line 2 by Physician-​Scientist Dr. Steven Quay PR Newswire
28.10.20 - PR Newswire
New Research Points to the People's Liberation Army Hospital in Wuhan, China as the Origin for the Worldwide Coronavirus Pandemic
New Research Points to the People's Liberation Army Hospital in Wuhan, China as the Origin for the Worldwide Coronavirus Pandemic PR Newswire
28.10.20 - PR Newswire
Neue Forschung verweist auf das Krankenhaus der Volksbefreiungsarmee in Wuhan als Ursprungsort der weltweiten Coronavirus-Pandemie
Neue Forschung verweist auf das Krankenhaus der Volksbefreiungsarmee in Wuhan als Ursprungsort der weltweiten Coronavirus-​Pandemie PR Newswire
28.10.20 - PR Newswire
New Research Points to the People's Liberation Army Hospital in Wuhan, China as the Origin for the Worldwide Coronavirus Pandemic
New Research Points to the People's Liberation Army Hospital in Wuhan, China as the Origin for the Worldwide Coronavirus Pandemic PR Newswire
02.10.20 - PR Newswire
Physician-Scientist Dr. Steven Quay Provides Best-Selling Book, "Stay Safe: A Physician's Guide to Survive Coronavirus," to the White House Upon the News of COVID in the First Family
Physician-​Scientist Dr. Steven Quay Provides Best-​Selling Book, "Stay Safe: A Physician's Guide to Survive Coronavirus," to the White House Upon the News of COVID in the First ...
14.09.20 - PR Newswire
Physician-Scientist Dr. Steven Quay's "Stay Safe: A Physician's Guide to Survive Coronavirus" Reaches #1 on Five Amazon Bestsellers Lists
Physician-​Scientist Dr. Steven Quay's "Stay Safe: A Physician's Guide to Survive Coronavirus" Reaches #1 on Five Amazon Bestsellers Lists "The Guide Offers Simple Tips to Help ...
08.09.20 - PR Newswire
Physician-Scientist Dr. Steven Quay Shares Back-to-School Tips To Stay Safe and Survive Coronavirus
Physician-​Scientist Dr. Steven Quay Shares Back-​to-School Tips To Stay Safe and Survive Coronavirus "Simple and Affordable Salt Spray Uses Everyday Household Ingredients to ...

Newssuche

Videos

newspaper
08:55 Uhr +6,89%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »